Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA Announces Change in Status of 12 Peptides SSRP Institute New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,